Logo image of AMRS

AMYRIS INC (AMRS) Stock Price, Forecast & Analysis

USA - NASDAQ:AMRS - US03236M2008 - Common Stock

0.05 USD
-0.01 (-21.87%)
Last: 8/18/2023, 8:19:54 PM
0.052 USD
+0 (+4%)
After Hours: 8/18/2023, 8:19:54 PM

AMRS Key Statistics, Chart & Performance

Key Statistics
Market Cap18.47M
Revenue(TTM)268.22M
Net Income(TTM)-614.55M
Shares369.39M
Float248.23M
52 Week High4.86
52 Week Low0.05
Yearly DividendN/A
Dividend YieldN/A
EPS(TTM)-1.67
PEN/A
Fwd PEN/A
Earnings (Next)11-06 2023-11-06/amc
IPO2010-09-28
Sector
GICS SectorMaterials
GICS IndustryChemicals
GICS IndustryGroupMaterials
GICS SubIndustrySpecialty Chemicals


AMRS short term performance overview.The bars show the price performance of AMRS in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months -20 -40 -60 -80

AMRS long term performance overview.The bars show the price performance of AMRS in the last 1, 2 and 3 years. 1 year 2 years 3 years -20 -40 -60 -80

The current stock price of AMRS is 0.05 USD. In the past month the price decreased by -94.62%. In the past year, price decreased by -98.26%.

AMYRIS INC / AMRS Daily stock chart

AMRS Latest News, Press Relases and Analysis

AMRS Competitors/Peers

The largest stocks on the US markets in the "Specialty Chemicals" sub-industry
Full List
Symbol
Company Name
TA
FA
PE
Market Cap
SHW SHERWIN-WILLIAMS CO/THE29.583.19B
ECL ECOLAB INC34.8171.77B
PPG PPG INDUSTRIES INC12.3921.48B
DD DUPONT DE NEMOURS INC8.9616.40B
IFF INTL FLAVORS & FRAGRANCES14.3816.11B
RPM RPM INTERNATIONAL INC19.8313.58B
ALB ALBEMARLE CORPN/A10.74B
NEU NEWMARKET CORP16.147.18B
EMN EASTMAN CHEMICAL CO9.156.85B
ESI ELEMENT SOLUTIONS INC18.216.47B
AXTA AXALTA COATING SYSTEMS LTD11.296.11B
BCPC BALCHEM CORP30.634.94B

About AMRS

Company Profile

AMRS logo image Amyris, Inc. engages in the provision of bioscience solutions. The company is headquartered in Emeryville, California and currently employs 1,598 full-time employees. The company went IPO on 2010-09-28. The component of the Company is derived from marketing and selling Clean Beauty, Personal Care, and Health & Wellness consumer products through its direct-to-consumer e-commerce platforms and a growing network of retail partners. The Company’s sustainable ingredients are sold in bulk to industrial leaders who serve Flavor & Fragrance (F&F), Nutrition, Food & Beverage, and Clean Beauty & Personal Care end markets. The ingredients and consumer products it produces by its Lab-to-Market technology platform. The firm leverages machine learning, robotics, and artificial intelligence, which enables its technology platform to rapidly bring new market at commercial scale. The Lab-to-Market technology platform utilizes optimized and automated molecular biology, analytical, and process development tools combined with machine learning algorithms and statistical models to transform the way microbes metabolize sugars.

Company Info

AMYRIS INC

5885 Hollis St Ste 100

Emeryville CALIFORNIA 94608 US

CEO: John G. Melo

Employees: 1598

AMRS Company Website

Phone: 15104500761.0

AMYRIS INC / AMRS FAQ

What does AMRS do?

Amyris, Inc. engages in the provision of bioscience solutions. The company is headquartered in Emeryville, California and currently employs 1,598 full-time employees. The company went IPO on 2010-09-28. The component of the Company is derived from marketing and selling Clean Beauty, Personal Care, and Health & Wellness consumer products through its direct-to-consumer e-commerce platforms and a growing network of retail partners. The Company’s sustainable ingredients are sold in bulk to industrial leaders who serve Flavor & Fragrance (F&F), Nutrition, Food & Beverage, and Clean Beauty & Personal Care end markets. The ingredients and consumer products it produces by its Lab-to-Market technology platform. The firm leverages machine learning, robotics, and artificial intelligence, which enables its technology platform to rapidly bring new market at commercial scale. The Lab-to-Market technology platform utilizes optimized and automated molecular biology, analytical, and process development tools combined with machine learning algorithms and statistical models to transform the way microbes metabolize sugars.


What is the current price of AMRS stock?

The current stock price of AMRS is 0.05 USD. The price decreased by -21.87% in the last trading session.


What is the dividend status of AMYRIS INC?

AMRS does not pay a dividend.


What is the ChartMill rating of AMYRIS INC stock?

AMRS has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 1 out of 10.


How is the market expecting AMRS stock to perform?

14 analysts have analysed AMRS and the average price target is 1.74 USD. This implies a price increase of 3384.94% is expected in the next year compared to the current price of 0.05.


Should I buy AMRS stock?

This depends on your investment goals. Check the Technical and Fundamental Analysis tabs for insights on AMRS.


What is the employee count for AMRS stock?

AMYRIS INC (AMRS) currently has 1598 employees.


AMRS Technical Analysis


Chartmill TA Rating
Chartmill Setup Rating

AMRS Fundamental Analysis

ChartMill assigns a fundamental rating of 1 / 10 to AMRS. AMRS may be in some trouble as it scores bad on both profitability and health.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

AMRS Financial Highlights

Over the last trailing twelve months AMRS reported a non-GAAP Earnings per Share(EPS) of -1.67. The EPS decreased by -595.83% compared to the year before.


Industry RankSector Rank
PM (TTM) N/A
ROA N/A
ROE N/A
Debt/Equity N/A
Chartmill High Growth Momentum
EPS Q2Q%2.94%
Sales Q2Q%-2.82%
EPS 1Y (TTM)-595.83%
Revenue 1Y (TTM)-32.87%

AMRS Forecast & Estimates

14 analysts have analysed AMRS and the average price target is 1.74 USD. This implies a price increase of 3384.94% is expected in the next year compared to the current price of 0.05.

For the next year, analysts expect an EPS growth of 67.21% and a revenue growth 76.61% for AMRS


Analysts
Analysts72.86
Price Target1.74 (3380%)
EPS Next Y67.21%
Revenue Next Year76.61%

AMRS Ownership

Ownership
Inst Owners0%
Ins Owners4.57%
Short Float %N/A
Short RatioN/A